Two independent groups have reported that immunisation with bee and snake venom produces IgE responses that increase host resistance to challenge with potentially lethal doses of venom through IgE receptors and associated mast cells. In summary, people who are able to develop an IgE immune response and recruit basophils or mast cells to the tick-bite site can show higher resistance to tick infestations and tick-borne diseases, but might face major risks of anaphylactic reactions to cetuximab and red meat. The implications of the strong Th2-type response induced by ticks in the development of host allergic reactions should be assessed to understand the balance between tick resistance and susceptibility and allergic clinical output. The carbohydrate alpha-gal seems to be a good model antigen. The use of tick salivary antigens to induce antivenom-like IgE Th2-type protective immune responses should be explored to develop anti-tick vaccines.
